Mein Warenkorb

EGF

EGF Molekülinformation

Englischer NameEpidermal growth factorAnzahl der inverkehr gebrachten Arzneimittel0
Anzahl der klinischen Arzneimittel2Target-AliasEpidermal Growth Factor (Beta-Urogastrone),Beta-Urogastrone,Urogastrone,URG,EGF,HOMG4,Epidermal Growth Factor,Pro-Epidermal Growth Factor
Höchste Forschungs- und EntwicklungsphasePhase 2 Clinical
Englischer NameEpidermal growth factor
Target-AliasEpidermal Growth Factor (Beta-Urogastrone),Beta-Urogastrone,Urogastrone,URG,EGF,HOMG4,Epidermal Growth Factor,Pro-Epidermal Growth Factor
Anzahl der inverkehr gebrachten Arzneimittel0
Anzahl der klinischen Arzneimittel2
Höchste Forschungs- und EntwicklungsphasePhase 2 Clinical

EGF Produktliste

  • Attribut

    Protein (7)Kits (1)

  • Produktbibliothek

    Online (7)In Forschung (1)

  • Spezies

    Human (7)Mouse (1)

  • Etikett

    Mouse IgG Fc Tag (1)Fc Tag (1)His Tag (2)- (1)Tag Free (3)

  • Marker

    Unconjugated (6)- (1)AF488 Labeled (1)

EGF Molekülhintergrund

Human epidermal growth factor (EGF) is also known as HOMG4 and  URG,and is a growth factor that plays an important role in the regulation of cell growth, proliferation, and differentiation by binding to its receptor EGFR. Epidermal growth factor can be found in human platelets, macrophages, urine, saliva, milk, and plasma. EGF is the founding member of the EGF-family of proteins. Members of this protein family have highly similar structural and functional characteristics. All family members contain one or more repeats of the conserved amino acid sequence. The biological effects of salivary EGF include healing of oral and gastroesophageal ulcers, inhibition of gastric acid secretion, stimulation of DNA synthesis as well as mucosal protection from intraluminal injurious factors such as gastric acid, bile acids, pepsin, and trypsin and to physical, chemical and bacterial agents. Because of the increased risk of cancer by EGF, inhibiting it decreases cancer risk.

EGF Molekülalias

EGF,URG,HOMG4

Klinische Arzneimittelinformation

Englischer NameForschungscodeForschungsphaseFirmaIndikationenKlinische Studie
Recombinant anti-EGFR chimeric monoclonal antibody (Shanghai CP Guojian)CPGJ-602; 602; CPGJ602; CPGJ 602Phase 2 ClinicalSunshine GuoJian Pharmaceutical (Shanghai) Co LtdColorectal Neoplasms
Details
DZD-6008DZD6008; DZD-6008Phase 1 ClinicalDizal (Jiangsu) Pharmaceutical Co LtdCarcinoma, Non-Small-Cell Lung
Details

Produktrezensionen

  • W***I2025-11-07
    0Menschen mögen
    Used this product mainly for coating 96-well plates for ELISA to conduct competitive binding experiments. The results met expectations, the protein is stable, will purchase again in the future.
  • M***h2024-05-10
    0Menschen mögen
    Optimizing a CSC protocol with various human derived cell lines, and need to order different components of CSC medias to test out. This product, in my opinion, did help me achieve slightly more spheres than in the other medias I tested. The product itself arrived quickly, was package super well, and was super easy to use and store in aliquots. It undergoes several testings and the information is easily accessible, and best of all it's not super expensive!
  • Molekülinformation
  • Produktliste
  • Produktrezensionen
  • Klinische Arzneimittelinformation
Kontaktieren Sie uns